Marcus Antonius Van Dijk Mi Nk Therapeutics, Inc. (INKT) insider trading activity

INKT Quotes by TradingView

Marcus Antonius Van Dijk is Chief Scientific Officer of MiNK Therapeutics, Inc.. Currently has a direct ownership of 27,363 shares of INKT, which is worth approximately $19,427. The most recent transaction as insider was on Jan 09, 2023, when has been sold 24,265 shares (Common Stock) at a price of $2.32 per share, resulting in proceeds of $56,294. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K
0% 3M change
0% 12M change
Total Value Held $19,427

Marcus Antonius van Dijk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2023
SELL
Payment of exercise price or tax liability
$56,294 $2.32 p/Share
24,265 Reduced 47.0%
27,363 Common Stock
Jan 09 2023
BUY
Grant, award, or other acquisition
$119,776 $2.32 p/Share
51,628 Added 50.0%
51,628 Common Stock
MAv

Marcus Antonius Van Dijk

Chief Scientific Officer
New York, NY

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

News

Receive news related to MiNK Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INKT